NovaBridge Biosciences Operating Lease, Liability, Noncurrent
NovaBridge Biosciences (NBP) had Operating Lease, Liability, Noncurrent of $2.18 million as of 2025-12-31, per its 20-F filed 2026-04-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2026-04-07
- 2023-12-31: Operating Lease, Liability, Noncurrent 23.10M CNY.
- 2022-12-31: Operating Lease, Liability, Noncurrent 32.07M CNY.
- 2022-06-30: Operating Lease, Liability, Noncurrent 61.30M CNY.
- 2021-12-31: Operating Lease, Liability, Noncurrent 81.79M CNY.
CNY
| Period end | Operating Lease, Liability, Noncurrent |
|---|---|
| 2023-12-31 | 23.10M CNY 20-F · filed 2024-04-30 |
| 2022-12-31 | 32.07M CNY 20-F · filed 2024-04-30 |
| 2022-06-30 | 61.30M CNY 6-K · filed 2022-11-10 |
| 2021-12-31 | 81.79M CNY 20-F · filed 2023-05-01 |
| 2020-12-31 | 5.54M CNY 20-F · filed 2022-04-29 |
| 2020-09-30 | 5.18M CNY 6-K · filed 2021-02-05 |
| 2019-12-31 | 7.49M CNY 20-F · filed 2021-04-28 |
USD
| Period end | Operating Lease, Liability, Noncurrent | Operating Lease, Liability, Noncurrent as first filed |
|---|---|---|
| 2025-12-31 | $2.18M 20-F · filed 2026-04-07 | |
| 2025-09-30 | $2.40M 6-K · filed 2025-12-18 | |
| 2025-06-30 | $2.63M 6-K · filed 2025-10-06 | |
| 2024-12-31 | $3.07M 20-F · filed 2026-04-07 | |
| 2023-12-31 | $3.26M 20-F · filed 2025-04-03 | $3.25M 20-F · filed 2024-04-30 |
| 2022-12-31 | $4.65M 20-F · filed 2023-05-01 | |
| 2022-06-30 | $9.15M 6-K · filed 2022-11-10 | |
| 2021-12-31 | $12.83M 20-F · filed 2022-04-29 | |
| 2020-12-31 | $849.00K 20-F · filed 2021-04-28 | |
| 2020-09-30 | $762.00K 6-K · filed 2021-02-05 | |
| 2019-12-31 | $1.08M 20-F · filed 2020-04-29 |